Canaccord Genuity Group Lowers InMode (NASDAQ:INMD) Price Target to $15.00
InMode (NASDAQ:INMD – Free Report) had its price target lowered by Canaccord Genuity Group from $17.00 to $15.00 in a research note released on Tuesday,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the healthcare company’s stock. INMD has been the topic of a number of other reports. Barclays lifted their price target […]
